Illumina To Buy Grail In $8B Deal
Update: 2025-10-09
Description
Narrow-moat genomic sequencing leader Illumina plans to acquire startup Grail for a cumulative interest of $8 billion, including Illumina's 12% diluted interest in the target.While Morningstar thinks Grail's liquid biopsy technology to detect cancers in very early stages holds significant promise in....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel